Skip to content

Clinical trials

Completed Phase 3 Basal Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Phase: Phase 3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20021
20032
20041
20091
20141
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Galderma R&D4
MEDA Pharma GmbH & Co. KG2
Biofrontera Bioscience GmbH1
Graceway Pharmaceuticals, LLC1
Queen's Medical Center1
Sol-Gel Technologies, Ltd.1
US Department of Veterans Affairs1
University of Ioannina1
University of Wisconsin, Madison1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma13
Carcinoma, Squamous Cell2
Basal Cell Nevus Syndrome1
Bowen's Disease1
Keratosis, Actinic1
Skin Neoplasms1
Warts1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.